Skip to main content

QuidelOrtho Corp

For the period ended Dec 31, 2023. Filed Feb 29, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 29, 2024

QDEL$11.52-4.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

Fiscal Year Ended
202320222021
OPERATING ACTIVITIES:
Net (loss) income$(10.1)$548.7$704.2
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization457.2283.652.7
Stock-based compensation expense51.648.425.4
Net change in operating lease right-of-use assets and liabilities—18.43.0
Payment of accreted interest on contingent and deferred consideration(9.7)(10.4)(8.2)
Loss on extinguishment of debt—24.0—
Unwind inventory fair value adjustment—60.6—
Other non-cash, net(13.9)(34.8)31.6
Changes in assets and liabilities:
Accounts receivable160.0150.2118.9
Inventories(211.6)(116.9)(85.0)
Prepaid expenses and other current and non-current assets(26.9)(26.2)(13.3)
Accounts payable3.023.510.4
Accrued payroll and related expenses(53.9)18.25.0
Income taxes payable(59.6)(26.8)(66.7)
Other current and non-current liabilities(5.9)(75.2)27.9
Net cash provided by operating activities280.2885.3805.9
INVESTING ACTIVITIES
Acquisitions of property, equipment, investments and intangibles(209.3)(140.9)(292.8)
Acquisition of businesses, net of cash and restricted cash acquired—(1,511.4)—
Proceeds from government assistance allocated to fixed assets13.518.436.9
Purchases of marketable securities(60.1)(63.7)(67.4)
Proceeds from sale of marketable securities78.353.43.8
Other payments(10.0)——
Net cash used for investing activities(187.6)(1,644.2)(319.5)
FINANCING ACTIVITIES
Proceeds from issuance of common stock11.626.47.6
Short-term borrowings, net1.6——
Proceeds from long-term borrowings, net of debt issuance costs—2,734.5—
Payments on long-term borrowings and extinguishment costs(228.0)(2,388.3)(0.3)
Payments of tax withholdings related to vesting of stock-based awards(13.5)(8.6)(37.1)
Repurchases of common stock(7.2)(74.3)(103.5)
Principal payments of acquisition contingent consideration—(4.2)(4.7)
Principal payments of deferred consideration(30.3)(33.5)(35.1)
Net cash (used for) provided by financing activities(265.8)252.0(173.1)
Effect of exchange rates on cash(1.2)(2.0)(0.4)
Net (decrease) increase in cash, cash equivalents and restricted cash(174.4)(508.9)312.9
Cash, cash equivalents and restricted cash at beginning of period293.9802.8489.9
Cash, cash equivalents and restricted cash at end of period$119.5$293.9$802.8
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for interest$150.0$95.1$—
Cash paid during the period for income taxes$86.6$264.8$235.6
Purchase of property, equipment and intangibles by incurring current liabilities$40.6$40.4$10.5
Transfer of instrument inventories to fixed assets$154.6$73.7$—
Reduction of other current liabilities upon issuance of restricted share units$1.9$4.6$2.0
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.